Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis
- PMID: 25792214
- DOI: 10.1159/000362093
Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis
Abstract
Objective: To collect information on biobanking facilities in low- and middle-income countries (LMICs) as a first step towards establishing an LMIC biobank and cohort building network (BCNet) to support research, with a focus on cancer control.
Method: Sixty centres were identified from sources including cancer centres, universities, hospitals, and public health facilities and invited to participate in a survey between December 2012 and March 2013.
Results: Of the 27 centres (45%) that responded, most have existed for <10 years. They store between 1,000 and 1,000,000 research samples as well as samples remaining after clinical diagnosis. Sample storage is mostly in freezers, although 45% (9/20) of the centres do not have regular access to electricity. Biobank managers, sample management systems, and mechanisms for follow-up using linkages are uncommon. Many (80%; 21/26) of the centres have regulations to govern research, but regulations for the use of biobank resources (samples and data) are not well developed.
Conclusions: Biobanking facilities are being developed in LMICs. Shortcomings in international visibility, sample sharing regulations, standardization, quality assurance, and sample management systems could be alleviated by international networking. Stakeholders need to work together to increase access to high-quality biological resources for scientific research.
Similar articles
-
A Review of Regulatory Frameworks Governing Biobanking in the Low and Middle Income Member Countries of BCNet.Biopreserv Biobank. 2021 Oct;19(5):444-452. doi: 10.1089/bio.2020.0101. Epub 2021 May 3. Biopreserv Biobank. 2021. PMID: 33945303 Review.
-
Sustainability in Biobanking: Model of Biobank Graz.Biopreserv Biobank. 2015 Dec;13(6):410-20. doi: 10.1089/bio.2015.0087. Biopreserv Biobank. 2015. PMID: 26697910
-
Toward Global Biobank Integration by Implementation of the Minimum Information About BIobank Data Sharing (MIABIS 2.0 Core).Biopreserv Biobank. 2016 Aug;14(4):298-306. doi: 10.1089/bio.2015.0070. Epub 2016 Mar 15. Biopreserv Biobank. 2016. PMID: 26977825
-
The uniqueness of biobanks for neurological and psychiatric diseases: potentials and pitfalls.Pathobiology. 2014;81(5-6):237-244. doi: 10.1159/000369886. Epub 2015 Mar 16. Pathobiology. 2014. PMID: 25792212
-
Population biobanking and international collaboration.Pathobiology. 2014;81(5-6):276-285. doi: 10.1159/000357527. Epub 2015 Mar 16. Pathobiology. 2014. PMID: 25792216 Review.
Cited by
-
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.J Invest Dermatol. 2022 Nov;142(11):2920-2928.e5. doi: 10.1016/j.jid.2022.05.1059. Epub 2022 Jun 1. J Invest Dermatol. 2022. PMID: 35659939 Free PMC article.
-
Bridging gaps between images and data: a systematic update on imaging biobanks.Eur Radiol. 2022 May;32(5):3173-3186. doi: 10.1007/s00330-021-08431-6. Epub 2022 Jan 10. Eur Radiol. 2022. PMID: 35001159 Review.
-
Cancer oriented biobanks: A comprehensive review.Oncol Rev. 2018 May 11;12(1):357. doi: 10.4081/oncol.2018.357. eCollection 2018 Jan 30. Oncol Rev. 2018. PMID: 30057691 Free PMC article.
-
Biobanking in a Challenging African Environment: Unique Experience from the SIREN Project.Biopreserv Biobank. 2018 Jun;16(3):217-232. doi: 10.1089/bio.2017.0113. Epub 2018 May 7. Biopreserv Biobank. 2018. PMID: 29733683 Free PMC article.
-
How inclusive are cell lines in preclinical engineered cancer models?Dis Model Mech. 2022 May 1;15(5):dmm049520. doi: 10.1242/dmm.049520. Epub 2022 Jun 1. Dis Model Mech. 2022. PMID: 35642685 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources